Major research interests are to identify and characterize novel human monoclonal antibodies (mAbs) as candidate therapeutics as well as to develop novel strategies to increase their safety and efficacy.
Evaluating therapeutics antibodies in clinical trials.
Chairman’s Gold Medal Recipient, Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Federal Government, 2013